Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	189,217	200,675	339,731	144,635	149,085	186,048
Market Cap Growth	-43.65%	-40.93%	134.89%	-2.99%	-19.87%	-37.31%
Enterprise Value	226,400	234,635	367,642	174,909	188,576	192,882
Last Close Price	3145.00	3808.46	6469.68	2821.08	2995.05	5148.47
PS Ratio	3.19	3.38	3.88	2.03	2.89	3.23
PB Ratio	2.60	2.76	3.19	1.39	1.44	2.15
P/TBV Ratio	2.74	2.91	3.32	1.46	1.52	2.43
P/OCF Ratio	-	-	59.28	48.35	-	-
EV/Sales Ratio	3.82	3.95	4.20	2.45	3.66	3.35
EV/EBITDA Ratio	-	-	208.45	22.04	-	-
EV/EBIT Ratio	-	-	-	37.14	-	-
Debt / Equity Ratio	0.58	0.58	0.34	0.40	0.58	0.97
Debt / EBITDA Ratio	-	-	20.70	5.24	-	-
Net Debt / Equity Ratio	0.51	0.51	0.25	0.23	0.33	0.23
Net Debt / EBITDA Ratio	-2.52	-2.52	15.03	3.01	-5.50	-1.43
Net Debt / FCF Ratio	-4.49	-4.49	-9.75	-15.60	-3.45	-0.73
Asset Turnover	0.34	0.34	0.49	0.40	0.27	0.26
Inventory Turnover	1.98	1.98	2.59	3.31	2.21	2.62
Quick Ratio	0.20	0.20	0.31	0.27	0.45	0.87
Current Ratio	0.43	0.43	0.62	0.70	0.60	1.08
Return on Equity (ROE)	-36.10%	-36.10%	-10.13%	-2.13%	-28.26%	-71.69%
Return on Assets (ROA)	-6.85%	-6.85%	-0.63%	1.63%	-3.21%	-5.54%
Return on Capital Employed (ROCE)	-21.80%	-21.80%	-1.60%	4.30%	-9.10%	-18.60%
Earnings Yield	-17.14%	-16.16%	-2.94%	-2.32%	-26.77%	-37.33%
FCF Yield	-4.38%	-4.13%	-0.80%	-1.06%	-6.58%	-14.84%
Buyback Yield / Dilution	-3.65%	-3.65%	-0.09%	-9.69%	-33.41%	-24.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.